Lili He
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Canagliflozin ameliorates high-salt-induced renal injury and premature aging in male Dahl salt-sensitive rats, with associated changes in SIRT6/HIF-1α signaling.
Journal: Renal failure
Published: August 12, 2025
Canagliflozin improves high-salt-induced aortic arteriosclerosis and premature aging in dahl salt-sensitive rats through the SIRT6/HIF-1 α signaling pathway.
Journal: Molecular and cellular biochemistry
Published: February 04, 2025
Metabolomic Analysis of the Effects of Canagliflozin on HFpEF Rats and Its Underlying Mechanism
Journal: Endocrine, metabolic & immune disorders drug targets
Published: December 03, 2024
Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats.
Journal: Renal failure
Published: January 08, 2024
Canagliflozin and irbesartan ameliorate renal fibrosis via the TGF-β1/Smad signaling pathway in Dahl salt-sensitive rats.
Journal: The Journal of international medical research
Published: October 20, 2023
Canagliflozin Ameliorates Ventricular Remodeling through Apelin/Angiotensin-Converting Enzyme 2 Signaling in Heart Failure with Preserved Ejection Fraction Rats.
Journal: Pharmacology
Published: March 04, 2023
MiR-21 attenuates FAS-mediated cardiomyocyte apoptosis by regulating HIPK3 expression.
Journal: Bioscience reports
Published: January 07, 2023
Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress.
Journal: Biochemical and biophysical research communications
Published: January 07, 2023
Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice.
Journal: Drug design, development and therapy
Published: September 05, 2022
An Effective Sodium-Dependent Glucose Transporter 2 Inhibition, Canagliflozin, Prevents Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.
Journal: Frontiers in pharmacology
Published: January 17, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026